title: Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.
abstract: Multiple sclerosis (MS) can be a debilitating neurological condition that attributes significant morbidity to bladder dysfunction. Although many effective treatment options exist, symptomatic patients are often underdiagnosed and undertreated. The purpose of this article is to give an overview of the current literature including new screening tools to identify symptomatic patients and updates on treatment options including medications, botulinum toxin, and neuromodulation.
authors.affiliation: Department of Urology, New York University Langone Medical Center, 150 East 32nd Street, 2nd Floor, New York, NY, 10016, USA, Areeba.Sadiq@med.nyu.edu.
authors.forename: Areeba
authors.initials: A
authors.lastname: Sadiq
authors.forename: Benjamin M
authors.initials: BM
authors.lastname: Brucker
mesh_terms: D000818:Animals; D001905:Botulinum Toxins / Q000627:therapeutic use; D005081:Exercise Therapy; D006801:Humans; D009103:Multiple Sclerosis / Q000150:complications*; D016896:Treatment Outcome; D014570:Urologic Diseases / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D014732:Vibration
chemical_list: D001905:Botulinum Toxins